| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.62 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |